Stifel maintains Buy on Alto Neuroscience stock, $10 target
Stifel analysts maintained a Buy rating and a $10.00 price target for Alto Neuroscience (NYSE: ANRO), suggesting a positive outlook for the company's stock. Currently trading at $3.15 and near its ...
Stifel maintains Buy on Iovance Biotherapeutics, target at $21
Stifel analysts maintained their Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA), currently trading at $5.24, with a steady price target of $21.00. According to InvestingPro data, analyst targets ...